A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease

This study will evaluate the safety and efficacy o fRefresh Optive® Gel Drops in patients with dry eye disease.

Inclusion Criteria:

• Current use of an artificial tear product
• Visual acuity of at least 20/32 (while wearing glasses, if necessary).

Exclusion Criteria:

• Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study
• Cataract surgery, laser-assisted in situ keratomileusis [LASIK], or photorefractive keratectomy, within the last 6 months
• Current eye infection or inflammation